LQDA Liquidia
- 12.060
- -0.420-3.37%
- 12.410
- +0.350+2.90%
Liquidia News
Even Though Liquidia (NASDAQ:LQDA) Has Lost US$56m Market Cap in Last 7 Days, Shareholders Are Still up 343% Over 3 Years
Liquidia Corporation (NASDAQ:LQDA) shareholders have seen the share price descend 19% over the month. But over the last three years the stock has shone bright like a diamond. In fact, the share pr
Express News | Liquidia Announces Poster Presentation at the American Thoracic Society (ATS) 2024 International Conference on Its Open-Label Safety Study of L606 (Liposomal Treprostinil) in Patients With Pah and Ph-Ild
Liquidia Corporation to Present at BofA Securities Health Care Conference 2024
MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Michael Kaseta, chief operating officer and chief financial officer, will provide an upda
Liquidia Corporation to Report First Quarter 2024 Financial Results On May 14, 2024
MORRISVILLE, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that it will report its first quarter 2024 financial results on May 14, 2024. The company will
Jim Cramer: You're 'Dice Rolling' With This Biopharma Stock, But Vista Energy Is 'A Good Situation'
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare, Inc. (NYSE:NET). "I would buy it slowly because we've got big selling going on in AI stock Meta," he added.On April 17,
When Will Liquidia Corporation (NASDAQ:LQDA) Become Profitable?
Liquidia(LQDA.US) Officer Sells US$22,558.32 in Common Stock
$Liquidia(LQDA.US)$ Officer Saggar Rajeev sold 1,649 shares of common stock on Apr 19, 2024 at an average price of $13.68 for a total value of $22,558.32.Source: Announcement What is statement of chan
Liquidia(LQDA.US) Officer Sells US$30,034.8 in Common Stock
$Liquidia(LQDA.US)$ Officer Schundler Russell sold 2,060 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $30,034.8.Source: Announcement What is statement of c
Liquidia(LQDA.US) Officer Sells US$22,234.5 in Common Stock
$Liquidia(LQDA.US)$ Officer Saggar Rajeev sold 1,525 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $22,234.5.Source: Announcement What is statement of chang
Liquidia(LQDA.US) Officer Sells US$121.89K in Common Stock
$Liquidia(LQDA.US)$ Officer JEFFS ROGER sold 8,360 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $121.89K.Source: Announcement What is statement of changes
Liquidia(LQDA.US) Officer Sells US$23,109.3 in Common Stock
$Liquidia(LQDA.US)$ Officer Moomaw Scott sold 1,585 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $23,109.3.Source: Announcement What is statement of change
Liquidia(LQDA.US) Officer Sells US$45,722.88 in Common Stock
$Liquidia(LQDA.US)$ Officer Kaseta Michael sold 3,136 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $45,722.88.Source: Announcement What is statement of cha
Liquidia(LQDA.US) Officer Sells US$17,335.62 in Common Stock
$Liquidia(LQDA.US)$ Officer Adair Jason sold 1,189 shares of common stock on Apr 12, 2024 at an average price of $14.58 for a total value of $17,335.62.Source: Announcement What is statement of change
Institutional Investors May Overlook Liquidia Corporation's (NASDAQ:LQDA) Recent US$134m Market Cap Drop as Long-term Gains Remain Positive
Key Insights Institutions' substantial holdings in Liquidia implies that they have significant influence over the company's share price A total of 9 investors have a majority stake in the company wi
Buy Rating for Liquidia Technologies: Innovation and Market Potential Drive Strong Investment Case
Liquidia Corporation (NASDAQ:LQDA) Has Caught the Attention of Institutional Investors Who Hold a Sizeable 38% Stake
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
MORRISVILLE, N.C., April 02, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ:LQDA) (Liquidia or the Company) announced today that Dr. Roger Jeffs, Chief Executive Officer, and Micheal Kaseta, Chief Operating
Analysts Offer Insights on Healthcare Companies: Rocket Pharmaceuticals (RCKT), Liquidia Technologies (LQDA) and Xtant Medical Holdings (XTNT)
The Analyst Landscape: 5 Takes On Liquidia
Liquidia (NASDAQ:LQDA) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below summarizes their recent ratings, show
Buy Rating Justified by Favorable Legal Outcomes and Imminent FDA Decision for Liquidia Technologies' Yutrepia
Analysis
Price Target
No Data
